Printer Friendly
The Free Library
19,122,083 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Procept Announces Third Quarter Financial Results.


CAMBRIDGE Cambridge, city, Canada
Cambridge (kām`brĭj), city (1991 pop. 92,772), S Ont., Canada, on the Grand River, NW of Hamilton. It was formed in 1973 with the amalgamation of Galt, Hespeler, and Preston, all founded in the early 19th cent.
, Mass.--(BW HealthWire)--Nov. 17, 1997-- Procept A procept is an amalgam of three components: a process which produces a mathematical object and a symbol which is used to represent either process or object. , Inc. (Nasdaq:PRCT PRCT Practice
PRCT Prospective, Randomized, Controlled Trial (medicine)
PRCT Partial Rotator Cuff Tear
) today announced its financial results for the third quarter of 1997. The Company reported that revenue decreased to $142,000 in the third quarter of 1997 compared with $788,000 in the third quarter of 1996. For the nine-month period ended September 30, 1997, revenue was $569,000 versus revenue of $1,935,000 for the same period last year. The net loss was $1,969,000 or $.80 per share for the third quarter of 1997 compared with a net loss of $2,494,000 or $1.29 per share, for the comparable period last year. For the nine-month period ended September 30, 1997, the net loss was $6,873,000 or $3.23 per share versus a net loss of $8,502,000 or $5.50 per share, for the same period last year.

As of September 30, 1997, the Company had cash and cash equivalents of $2.4 million and there were approximately 2.0 million shares of common stock outstanding.

Procept, Inc. is engaged in the research and development of small molecule therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 for the prevention and treatment of chronic and life-threatening immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 disorders. Procept is developing therapeutics for the treatment of arthritis arthritis, painful inflammation of a joint or joints of the body, usually producing heat and redness. There are many kinds of arthritis. In its various forms, arthritis disables more people than any other chronic disorder. , diabetes, organ transplant organ transplant: see transplantation, medical.  rejection and infectious diseases infectious diseases: see communicable diseases. , including AIDS and tuberculosis tuberculosis (TB), contagious, wasting disease caused by any of several mycobacteria. The most common form of the disease is tuberculosis of the lungs (pulmonary consumption, or phthisis), but the intestines, bones and joints, the skin, and the genitourinary, . Founded in 1985 and traded on the Nasdaq National Market System under the symbol PRCT, Procept is located in Cambridge, Massachusetts This article is about the city of Cambridge in Massachusetts. For the English university town, see Cambridge, England. For other places, see Cambridge (disambiguation).
Cambridge, Massachusetts is a city in the Greater Boston area of Massachusetts, United States.
.

PROCEPT, INC.
CONDENSED STATEMENTS OF OPERATIONS
(in thousands, except share data)


                            Three Months Ended     Nine Months Ended
                               September 30,        September 30,
                             1997       1996      1997        1996

Revenues                  $   142    $   788    $   569    $   1,935

Costs and Expenses:
  Research and development  1,287      2,280      5,166        7,752
  General and administrative  592        690      2,017        2,310
  Restructuring charges       221        273        221          273
  Other expenses               11         39         38          102

Total costs and expenses    2,111      3,282      7,442       10,437


Net income (loss)         $(1,969)   $(2,494)   $(6,873)   $  (8,502)


Net income (loss) per
  common share            $ (0.80)   $ (1.29)   $ (3.23)   $   (5.50)

Weighted average number
  of common shares
  outstanding          $2,452,269  $1,936,785  $2,127,804  $1,545,617


CONDENSED BALANCE SHEETS
(in thousands)                          September 30,   December 31,
                                            1997            1996
ASSETS

Cash, cash equivalents, and
  marketable securities                 $    2,419    $     5,964
Other current assets                           195            284
    Total current assets                     2,614          6,248


Property and equipment, net             $    1,139    $     1,863
Restricted investment                          -              469
Deposits                                       250            136
Other assets                                   312            201


TOTAL ASSETS                            $    4,315    $     8,917


LIABILITIES AND STOCKHOLDERS' EQUITY

Accounts payable                        $      727    $       773
Accrued expenses                               614            561
Capital lease obligations                      136            634
Other liabilities                              460            632
    Total liabilities                   $    1,937    $     2,600


Stockholders' equity:
Preferred stock, par value $0.01 per share     -              -
Common stock, par value $0.01 per share         20             20
Additional paid-in capital                  57,934         55,005
Accumulated deficit                        (55,576)       (48,708)
    Total stockholders' equity               2,378          6,317

TOTAL LIABILITIES AND STOCKHOLDERS'
   EQUITY                               $    4,315    $     8,917





CONTACT: Procept, Inc.

Stanley Stanley, town (1991 pop. 1,557), capital of the Falkland Islands, S Atlantic Ocean, on East Falkland island. It is the main port and trading center of the islands. The name is sometimes written as Port Stanley.  C. Erck

(617) 491-1100

serck@procept.com
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 17, 1997
Words:508
Previous Article:StarBase Corp. Announces Results of Operations for the Quarter Ended Sept. 30, 1997.
Next Article:Innovative Medical Services Announces Chain-Wide Use of Fillmaster Purification System at Walgreens; Fillmaster Enhances Efficiency and Customer...
Topics:



Related Articles
Procept, Inc. announces 1995 financial results.
Procept Announces the Receipt of Additional $1 Million Funding for VacTex.
Procept announces first quarter financial results.
Procept Announces Second Quarter Financial Results.
Procept Announces Private Financing.
Antiviral gel clears safety test.
Procept Raises $9.6 Million in Private Placement of Equity Securities.
Procept Raises $9.6 Million in Private Placement of Equity Securities.
Procept Announces First Quarter Results; Company Plans To File IND and Initiate Further Clinical Trials for PRO 2000 Gel During 1998.
Procept Announces Second Quarter Results; Company Completes Restructuring to Enhance Development of PRO 2000 Gel.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles